Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy.

    Kanwar M, Kowluru RA.

    Diabetes. 2009 Jan;58(1):227-34. Epub 2008 Oct 13.PMID: 18852331 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glyceraldehyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopathy.

    Madsen-Bouterse S, Mohammad G, Kowluru RA.

    Invest Ophthalmol Vis Sci. 2009 Oct 29. [Epub ahead of print]PMID: 19875652 [PubMed - as supplied by publisher]Related articles

    3.

    Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells.

    Kusner LL, Sarthy VP, Mohr S.

    Invest Ophthalmol Vis Sci. 2004 May;45(5):1553-61.PMID: 15111614 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.

    Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M.

    Nat Med. 2003 Mar;9(3):294-9. Epub 2003 Feb 18.PMID: 12592403 [PubMed - indexed for MEDLINE]Related articles

    6.

    Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kappaB) in the retina.

    Kowluru RA, Chakrabarti S, Chen S.

    Acta Diabetol. 2004 Dec;41(4):194-9.PMID: 15660203 [PubMed - indexed for MEDLINE]Related articles

    7.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.

    Kowluru RA, Engerman RL, Kern TS.

    Curr Eye Res. 2000 Oct;21(4):814-9.PMID: 11120572 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hyperglycemia increases mitochondrial superoxide in retina and retinal cells.

    Du Y, Miller CM, Kern TS.

    Free Radic Biol Med. 2003 Dec 1;35(11):1491-9.PMID: 14642397 [PubMed - indexed for MEDLINE]Related articles

    9.

    Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.

    de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW.

    Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5561-8.PMID: 17122149 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy.

    Kowluru RA, Atasi L, Ho YS.

    Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1594-9.PMID: 16565397 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.

    Kanwar M, Chan PS, Kern TS, Kowluru RA.

    Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3805-11.PMID: 17652755 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Analysis of glucose metabolism in diabetic rat retinas.

    Ola MS, Berkich DA, Xu Y, King MT, Gardner TW, Simpson I, LaNoue KF.

    Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1057-67. Epub 2005 Dec 27.PMID: 16380392 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

    Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.PMID: 11053301 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries.

    Kowluru RA, Kanwar M, Kennedy A.

    Exp Diabetes Res. 2007;2007:21976.PMID: 17641740 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos.

    Wentzel P, Ejdesjö A, Eriksson UJ.

    Diabetes. 2003 May;52(5):1222-8.PMID: 12716756 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid.

    Berkowitz BA, Roberts R, Stemmler A, Luan H, Gradianu M.

    Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4753-8.PMID: 17898301 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.

    Kowluru RA, Menon B, Gierhart DL.

    Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1645-51.PMID: 18385086 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

    Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP.

    Diabetes. 2007 Feb;56(2):373-9.PMID: 17259381 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Retinal ion regulation in a mouse model of diabetic retinopathy: natural history and the effect of Cu/Zn superoxide dismutase overexpression.

    Berkowitz BA, Gradianu M, Bissig D, Kern TS, Roberts R.

    Invest Ophthalmol Vis Sci. 2009 May;50(5):2351-8. Epub 2008 Dec 13.PMID: 19074809 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data